CE: Dermatology updates for busy veterinarians: practice pearls from a dermatologist
Episode 198, Aug 02, 2023, 08:55 PM
This podcast is sponsored by Zoetis. This podcast is RACE-approved for CE credit. Head to dvm360 Flex and login or create a free CE account and claim your credit after listening to this episode.
In this presentation, Dr. Liska will provide real world tips for your dermatology patients, including how to get your practice ready for Itchy Pet Awareness Month in August. Dr. Liska will present data on Apoquel’s® (oclacitinib tablet) ability to treat both itch and inflammation due to allergic dermatitis, share the lack of evidence for antihistamine efficacy for treating dogs with allergic dermatitis, and will share how to maximize success with Cytopoint®.
Program Agenda:
In this presentation, Dr. Liska will provide real world tips for your dermatology patients, including how to get your practice ready for Itchy Pet Awareness Month in August. Dr. Liska will present data on Apoquel’s® (oclacitinib tablet) ability to treat both itch and inflammation due to allergic dermatitis, share the lack of evidence for antihistamine efficacy for treating dogs with allergic dermatitis, and will share how to maximize success with Cytopoint®.
Program Agenda:
- How getting it right the first time when treating canine allergic dermatitis benefits the pet, the owner and the practice
- Why it is important to avoid “phone fixes” to owners of itchy dogs
- Evidence to support that antihistamines are not effective in most cases of allergic dermatitis in dogs(1,2)
- Introduce Itchy Pet Awareness Month and how to get your practice ready for this important month in August. Will review what practice resources can be found on ItchyPetAwarenessMonth.com.
- Review the data that supports Apoquel’s ability to control inflammation due to allergic and atopic dermatitis as well as steroids(3)
- Will share a study supporting that some dogs with an initial partial response to Cytopoint may benefit from additional injections(4)
Learning Objectives:
- Learn how getting it right the first time when treating canine allergic dermatitis benefits the pet, the owner and the practice, and why it is important to avoid “phone fixes” to owners of itchy dogs
- Understand the evidence to support that antihistamines are not effective in most cases of allergic dermatitis in dogs(1,2)
- Introduce Itchy Pet Awareness Month and how to get your practice ready for this important month in August. Will review what practice resources can be found on ItchyPetAwarenessMonth.com.
- Review the data that supports Apoquel’s ability to control inflammation due to allergic and atopic dermatitis as well as steroids(3)
- Evaluate a study supporting that some dogs with an initial partial response to Cytopoint may benefit from additional injections(4)
References:
- Olivry et al. Treatment of canine atopic dermatitis: 2015 updated guidelines from the international committee on allergic diseases of animals. (ICADA). BMC Veterinary Research 2015;11:210.
- Hsiao YH, Chen C, Willemse T. Effects of cetirizine in dogs with chronic atopic dermatitis: a randomized, double blind, placebo-controlled trial. J Vet Sci. 2016 Dec 30;17(4):549-553.
- Gadeyne C, Little P, King VL, Edwards N, Davis K, Stegemann MR. Efficacy of oclacitinib (Apoquel®) compared with prednisolone for the control of pruritus and clinical signs associated with allergic dermatitis in client-owned dogs in Australia. Vet Dermatol. 2014 Dec;25(6):512–e86.
- Data on file, Study No. 17SP4DER-01-01 (v.3.0), 2019, Zoetis Inc.